Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.
about
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.Who Signs Up for and Engages in a Peer Support Heart Failure Self-management InterventionGood Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds.The role of the emergency department in acute heart failure clinical trials--enriching patient identification and enrollmentVariation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial.Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failureLearning from recent trials and shaping the future of acute heart failure trials.Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions.Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes.Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial.Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting†.Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial.International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial.Acute heart failure in the emergency department: a follow-up study.Geographic variation in heart failure trials: time for scepticism?Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry.Progress or lack of progress in hospitalized heart failure.Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?Factors influencing the enrollment in randomized controlled trials in orthopedics.REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study
P2860
Q34162294-9C139437-71F0-46A5-B52F-473CB2AF3849Q34772635-12CD44B3-612C-4A17-8B2D-21FBB5A52F6BQ36650748-E308A34D-36D2-4AC5-AB1A-EDB0226A1BA3Q36878538-40F79A09-6D77-4364-B0CF-EACC37F29196Q37036344-3B25482D-7595-4EBE-9559-2CE8A5982B63Q37457781-9448AE40-AE11-40A2-84D4-F3424EBD1332Q37531278-2A89AE9F-E9AD-4F15-B361-B30FB20B92B0Q37710165-1D28A042-9077-42AB-9018-F0EEEC0F1C0DQ38254025-55CA102F-A2AF-4580-94B2-C137BF88B315Q38430272-50413B03-F775-4EEE-9EAF-2BF6C74DD473Q38737378-1526669D-AB51-44A5-A4B0-B20465315445Q38777054-C5D3FA53-0DB3-439E-91EC-1A416598DAEAQ39012314-80296C7C-AFAC-4A67-86B6-6DCE8A64F3FAQ39202662-37FB0416-EFC1-4DC1-AF15-FE61539675E2Q41179736-FD88D7B0-FD57-47ED-B589-C573E7848147Q44635003-46E07EEE-3EF2-40C2-A237-1F20B580DD62Q45781910-F8F7964F-4161-472F-9BAF-6E1716D4EC68Q45904891-B08A640B-694D-4E97-BC9B-756FECCB6A58Q52660416-311E628D-BA92-4155-9705-432C69A155B1Q55409454-BA228E4C-95E7-44D2-8ABC-25B76FA093DAQ57630136-2042DFFA-B368-4AE7-949F-2C5DA05FC4A1
P2860
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Relationship between clinical ...... e Study with Tolvaptan) trial.
@en
Relationship between clinical ...... e Study with Tolvaptan) trial.
@nl
type
label
Relationship between clinical ...... e Study with Tolvaptan) trial.
@en
Relationship between clinical ...... e Study with Tolvaptan) trial.
@nl
prefLabel
Relationship between clinical ...... e Study with Tolvaptan) trial.
@en
Relationship between clinical ...... e Study with Tolvaptan) trial.
@nl
P2093
P50
P1476
Relationship between clinical ...... e Study with Tolvaptan) trial.
@en
P2093
Andrew P Ambrosy
EVEREST Investigators
Marvin A Konstam
Muthiah Vaduganathan
Robert J Mentz
P304
P356
10.1016/J.JACC.2012.10.025
P407
P50
P577
2012-12-12T00:00:00Z